SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-029337
Filing Date
2010-05-18
Accepted
2010-05-18 16:06:13
Documents
8
Period of Report
2010-05-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-10395_18k.htm 8-K 30659
2 EX-99.1 a10-10395_1ex99d1.htm EX-99.1 98955
3 EX-99.2 a10-10395_1ex99d2.htm EX-99.2 143727
4 GRAPHIC g103951mmi001.jpg GRAPHIC 14358
5 GRAPHIC g103951mmi002.jpg GRAPHIC 14851
6 GRAPHIC g103951mmi003.jpg GRAPHIC 1483
7 GRAPHIC g103951moi001.jpg GRAPHIC 11880
8 GRAPHIC g103951moi002.jpg GRAPHIC 1483
  Complete submission text file 0001104659-10-029337.txt   336353
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 10842615
SIC: 2834 Pharmaceutical Preparations